Navigation Links
Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary
Date:9/6/2011

TARRYTOWN, N.Y., Sept. 6, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced that Joseph J. LaRosa has been appointed Senior Vice President, General Counsel and Secretary.  Mr. LaRosa will be responsible for overseeing all of the Company's legal affairs, including general corporate legal matters, intellectual property and corporate compliance, and will report to Leonard S. Schleifer, M.D., Ph.D., president and chief executive officer.

"We are extremely pleased to have recruited a seasoned corporate attorney with deep senior-level pharmaceutical experience to lead this important function," said Dr. Schleifer.  "Joe's track record managing a variety of key legal functions at Schering-Plough and Nycomed will be directly relevant as Regeneron, which now employs more than 1,600 people, continues to build its product portfolio and the capabilities of a fully integrated pharmaceutical company."

Previously, Mr. LaRosa held a number of senior legal positions at Schering-Plough Corporation, where he was a corporate officer and served most recently as Vice President, Legal Affairs, and a member of the Operations Management Team.  He also served as Vice President, Global Compliance and Legal Affairs at Avon Products, Inc.  Most recently Mr. LaRosa was Senior Vice President, General Counsel and Secretary at Nycomed US Inc.

"I am excited to join the Regeneron senior management team at a time when the company is emerging as one of the best-positioned biotechnology companies," said Mr. LaRosa, who holds undergraduate and J.D. degrees from New York University.  "Regeneron is known for outstanding science and innovative collaborations with leading pharmaceutical companies, and in recent years it has also demonstrated its abilities in clinical development, manufacturing, and commercialization of new biotechnology-ba
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
2. Regeneron Announces Presentation at the 29th Annual J.P. Morgan Healthcare Conference
3. Regeneron Announces Presentation at the 2010 Deutsche Bank BioFest
4. Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
5. Regeneron Pharmaceuticals and BioMed Realty Trust Host Ribbon-Cutting Ceremony at the Landmark at Eastview
6. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
7. Genprex Announces New Branding
8. BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026
9. BioInformatics LLC Announces the Life Science Industry Awards on November 15, 2011 in Washington, DC
10. Jeunesse Global Announces New Medical Advisory Board Member and Admittance Into the Direct Selling Association (DSA).
11. BD Biosciences Announces Winners of Research Grant Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... Madison, WI (PRWEB) May 24, 2013 ... to the discovery and development of calcium-binding proteins ... publication of safety assessment study of apoaequorin ... an international journal published for the British Industrial ... the study was to investigate potential adverse effects, ...
(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
(Date:5/23/2013)... 2013 The maker community is a ... inventions. They focus on learning practical skills while applying ... toward bringing their ideas to life via crowdfunding. A ... on making projects using biology. Glowing Plant has worked ... make them glow with bioluminescence genes, and has now ...
(Date:5/23/2013)... 23, 2013 BioTrends Research Group, one ... for specialized biopharmaceutical issues, finds that, unaided, one ... specialists reported that in the past six months, ... treatment) in anticipation of the next generation of ... when only 6 percent reported that they had ...
Breaking Biology Technology:Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... Journal Indicates Masimo SET May Also Reduce the Need for ... Jan. 30 Masimo (Nasdaq: ... Motion and Low Perfusion pulse oximetry, today announced that a ... January 2009 issue of the British Medical Journal ...
... Stock Exchange Symbol: MSEDMONTON, Jan. 30 /PRNewswire-FirstCall/ - ... in the treatment of multiple sclerosis (MS), today ... clinical trial evaluating dirucotide in patients with relapsing-remitting ... is for secondary progressive MS where it is ...
... CA The logic and memory functions of future electronic ... (billionths of a meter) instead of the many tens of ... way can be found to control domain walls, the ultrathin ... magnetic, electric, or other properties. , In a ...
Cached Biology Technology:New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 2New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 3New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 4New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns 5BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 2BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 3BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 4BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis 5Domain walls that conduct electricity 2Domain walls that conduct electricity 3Domain walls that conduct electricity 4Domain walls that conduct electricity 5
(Date:5/23/2013)... Public Health at Emory University, along with partners ... a $4 million grant over four years to ... and Exposome Research Center: Understanding Lifetime Exposures). The ... in the United States. , The HERCULES ... Environmental Health Sciences (NIEHS) of the National Institutes ...
(Date:5/23/2013)... wrapping of genomic DNA around nucleosomes in the ... A team of Ludwig-Maximilians-Universitaet (LMU) in Munich now ... be locally displaced from nucleosomes for transcription. , ... in the cell nucleus, wrapped around disk-shaped particles ... four different histone proteins and accommodating two loops ...
(Date:5/23/2013)... unnecessarily undergo surgery or harsh treatments because science ... aggressive forms of the disease. Researchers at Case ... are developing technology that allows patients to safely ... treatments or take drastic measures. , The project ... professor of biomedical engineering at Case Western Reserve ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Biochemistry: Unspooling DNA from nucleosomal disks 2Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
... healthy men decline as they get older. As sleep ... in the amount of sleep a healthy older man gets ... to a study published in the April 1st issue of ... MD, PhD, of the University of Chicago, focused on 12 ...
... state-of-the-art technique to map neurons in the spinal cord ... a surprising pattern of activity that regulates the speed ... implications for treating injured human spinal cords and Parkinson’s ... The study, "A Topographic Map of Recruitment in Spinal ...
... delivery system using microspheres of a biodegradable polymer may not ... but also appears to stimulate an immune response that traditional ... their findings today at the ASM Biodefense and Emerging Disease ... that block entry into the cell. In the case ...
Cached Biology News:Fast and slow -- How the spinal cord controls the speed of movement 2Biodegradable microspheres deliver time release vaccines, stimulate different immune response 2
... InnoScan700 is a fluorescence scanner with ... biochip (Staggered/Orange Packing, Protein, CGH, ) spotted ... the range of InnoScan700 scanners include three ... InnoScan700A is a simultaneous dual fluorescence scanner ...
... neurons in vesicles called synaptosomes. ... bouton. Synaptosomes may be centrifuged ... cellular debris. Abnormalites in neurotransmitter release ... condtions. Conditions of release may ...
... Frame DNAscope is an integrated confocal laser ... readily integrated into your specific application. GeneFocus ... can tailor the system to your specifications. ... scanning design has been modularized and built ...
... CLS number is a ... to easily match Cornings ... no availability yet, please ... Sigma-Aldrich number (Z71,515-8) or ...
Biology Products: